Cargando…
Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China
Idiopathic pulmonary fibrosis (IPF), the prototype of interstitial lung diseases, has the worst prognosis and is the only interstitial lung disease for which approved pharmacological treatments are available. Despite being considered a rare disease, IPF patients pose major challenges to both physici...
Autores principales: | Richeldi, Luca, Rubin, Adalberto Sperb, Avdeev, Sergey, Udwadia, Zarir F., Xu, Zuo Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581420/ https://www.ncbi.nlm.nih.gov/pubmed/26399999 http://dx.doi.org/10.1186/s12916-015-0495-0 |
Ejemplares similares
-
Correction to: Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China
por: Richeldi, Luca, et al.
Publicado: (2021) -
An assessment of progress towards universal health coverage in Brazil, Russia, India, China, and South Africa (BRICS)
por: Marten, Robert, et al.
Publicado: (2014) -
Post-COVID lung fibrosis: The tsunami that will follow the earthquake
por: Udwadia, Zarir F, et al.
Publicado: (2021) -
Russia Says Nyet to Environmental Agency
por: Greene, LA
Publicado: (2000) -
Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in Brazil
por: Pereira, Carlos Alberto de Castro, et al.
Publicado: (2019)